Clinical Trial Update: High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-dose intravenous vitamin C in patients with resectable or metastatic solid tumors has completed, with results posted in May 2024. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• Vitamin C (intravenous) (ascorbic acid)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Colorectal Cancer, Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-05-02